EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Tailored Individual Follow-Ups Versus a One-Day Group Course in Patients With Long COVID (Post– COVID-19 Condition): Protocol for a Randomized Controlled Trial

Marte Wilson iD, Synne Garder Pedersen iD, Nina Langeland iD, Rebecca Jane Cox iD, Pål Aukrust iD, Tuva B Dahl iD, Axel Sandvig iD, Maja Wilhelmsen iD

JMIR Research Protocols · 2026

DOI: 10.2196/74113 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2026. Verfasst von Marte Wilson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, University Hospital of North Norway, Tromsø, Norway. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The high prevalence of patients with post–COVID-19 condition, also called long COVID, even among those with mild initial disease, may have a large impact on both the individual and society. Disability in everyday life, reduced health-related quality of life and work capacity, strain on the health care system, and substantial socioeconomic costs are associated with long COVID. More research to investigate the effectiveness of rehabilitation services is warranted.

Objective

This study aims to examine the effectiveness of tailored individual follow-ups versus a 1-day group course in patients with long COVID. Additionally, the feasibility and use of a mobile app for self-monitoring goal achievement will be assessed.

Methods

This is a single-center, parallel-group, superiority randomized controlled trial with a 1:1 allocation ratio. A total of 62 outpatients aged 18‐65 years with long COVID will be randomized to either a rehabilitation program with individual follow-up consultations or a 1-day self-management group course. The individual intervention incorporates setting goals, teaching cognitive behavioral strategies, energy management (pacing), and a supervised gradual increase in both physical and cognitive activities tailored to individual tolerance levels. The primary outcome is the between-group difference in health-related quality of life, measured using the EQ-5D-5L index at 6 months. Secondary outcomes include improvements in symptoms, work participation, neurocognitive function, and app usability, assessed at 3, 6, and 12 months, depending on the outcome measure.

Results

Data enrollment started in October 2023. A total of 62 participants were included by November 2024. Data collection is planned to be completed in November 2025.

Conclusions

Long COVID poses substantial challenges for both individuals and society, underscoring the need for effective rehabilitation strategies. This study will provide valuable insights into the benefits of an individualized outpatient rehabilitation program. The results from this clinical trial will help guide future treatment recommendations and may improve long-term outcomes for affected patients. Additionally, the study will generate important knowledge about neuropsychological function and digital self-management tools in long COVID rehabilitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansAdultMiddle AgedQuality of LifeAgedAdolescentYoung AdultMaleFemaleSARS-CoV-2Randomized Controlled Trials as TopicMobile ApplicationsSelf-ManagementPost-Acute COVID-19 SyndromeEquivalence Trials as Topic

Stichwörter der Autor:innen

cognitive behavioral therapycognitive trainingexercisefatiguegraded activitymobile appspostacute COVID-19 syndromerandomized controlled trialrehabilitationtelerehabilitation

Autor:innen und Institutionen

  • Department of Rehabilitation, University Hospital of North Norway, Tromsø, Norway.
  • Institute of Health and Society, Research Centre for Habilitation and Rehabilitation Model and Services (CHARM), Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Department of Medicine, Haukeland University Hospital, Bergen, Vestland, Norway.
  • Norwegian Institute for Public Health, Oslo, Norway.
  • Influenza Centre, Department of Microbiology, Haukeland University Hospital, Bergen, Vestland, Norway.

ORCID-Profile: Marte Wilson, Synne Garder Pedersen, Nina Langeland, Rebecca Jane Cox, Pål Aukrust, Tuva B Dahl, Axel Sandvig, Maja Wilhelmsen

Zitieren

APA

Wilson, M., Pedersen, S. G., Langeland, N., Cox, R. J., Aukrust, P., Dahl, T. B., Sandvig, A., & Wilhelmsen, M. (2026). Tailored Individual Follow-Ups Versus a One-Day Group Course in Patients With Long COVID (Post– COVID-19 Condition): Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/74113

Vancouver

Wilson M, Pedersen SG, Langeland N, Cox RJ, Aukrust P, Dahl TB, et al. Tailored Individual Follow-Ups Versus a One-Day Group Course in Patients With Long COVID (Post– COVID-19 Condition): Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2026. doi:10.2196/74113

BibTeX
@article{Wilson2026,
  author = {Wilson, Marte and Pedersen, Synne Garder and Langeland, Nina and Cox, Rebecca Jane and Aukrust, Pål and Dahl, Tuva B and Sandvig, Axel and Wilhelmsen, Maja},
  title = {Tailored Individual Follow-Ups Versus a One-Day Group Course in Patients With Long COVID (Post– COVID-19 Condition): Protocol for a Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  doi = {10.2196/74113}
}
Kostenlos starten →